Evaluation and management of atrial fibrillation

Medical Clinics of North America

Volumn 85, Issue 2, 2001, Pages 225-244

  Pelosi Jr , Frank ^b   Morady, Fred ^b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANTIARRHYTHMIC AGENT; AZIMILIDE; DILTIAZEM; DISOPYRAMIDE; DOFETILIDE; DRONEDARONE; ENCAINIDE; FLECAINIDE; IBUTILIDE; MORACIZINE; NIFEDIPINE; PROCAINAMIDE; PROPAFENONE; QUINIDINE; SOTALOL; VERAPAMIL; WARFARIN;

ALGORITHM; ANTIARRHYTHMIC ACTIVITY; ANTICOAGULATION; ARRHYTHMOGENESIS; CATHETER ABLATION; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIGITALIS INTOXICATION; DISEASE COURSE; GASTROINTESTINAL SYMPTOM; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; HEART DILATATION; HUMAN; HYPERTENSION; HYPERTHYROIDISM; HYPOTENSION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RHEUMATIC HEART DISEASE; THROMBOEMBOLISM; TREATMENT PLANNING;

EID: 0035113526     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7125(05)70314-X     Document Type: Article

References (91)

1. Experimental evaluation of Moe's multiple wavelet hypothesis of atrial fibrillation
2. Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction
3. Predictors of thromboembolism in atrial fibrillation: I. Clinical features of patients at risk
4. Predictors of thromboembolism in atrial fibrillation: II. Echocardiographic features of patients at risk
5. Proceedings of the American College of Chest Physicians 5th Consensus on Antithrombotic Therapy, 1998
6. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke
7. Stroke prevention in atrial fibrillation study: Final results
8. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation. Stroke prevention in atrial fibrillation II study
9. Evolution of the maze procedure: Are modifications necessary?
10. Changes in ultrastructural calcium distribution in goat atria during atrial fibrillation
11. Dedifferentiation of atrial cardiomyocytes as a result of chronic atrial fibrillation
12. Impact of atrial fibrillation on the risk of death: The Framingham Heart Study
13. Hospitalization for arrhythmias in the United States: Importance of atrial fibrillation
14. Characteristics and prognosis of lone atrial fibrillation: 30-year follow-up in the Framingham study
15. The azimilide post-infarct survival evaluation (ALIVE) trial
16. Conversion of recent-onset atrial fibrillation by a single oral loading dose of propafenone or flecainide
17. Canadian Atrial Fibrillation Anticoagulation (CAFA) study
18. Five-year experience with the maze procedure for atrial fibrillation
19. Effect of atrial fibrillation on atrial refractoriness in humans
20. Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery
21. Effect of an irregular ventricular rhythm on cardiac output
22. Factors influencing long term persistence of sinus rhythm after a first electrical cardioversion for atrial fibrillation
23. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial
24. Efficacy of ibutilide for termination of atrial fibrillation and flutter
25. Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: A dose-response study
26. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation
27. Cardiac biopsy in patients with "primary" atrial fibrillation: Histologic evidence of occult myocardial diseases
28. Histological substrate of atrial biopsies in patients with lone atrial fibrillation
29. Atrial fibrillation in elite athletes
30. Tachycardia-induced atrial myopathy: An important mechanism in the pathophysiology of atrial fibrillation?
31. Electrical remodeling in atrial fibrillation: Time course and mechanisms
32. Oral d,l sotalol reduces the incidence of postoperative atrial fibrillation in coronary artery bypass surgery patients: A randomized, double-blind, placebo-controlled study
33. Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy
34. Frequency of recurrent atrial fibrillation after catheter ablation of overt accessory pathways
35. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins
36. Electrophysiological end point for catheter ablation of atrial fibrillation initiated from multiple pulmonary venous foci
37. Clinical variables affecting recovery of left atrial mechanical function after cardioversion from atrial fibrillation
38. Electrocardiographic features in 122,043 individuals
39. A focal source of atrial fibrillation treated by discrete radiofrequency ablation
40. Efficacy and safety of septal and left-atrial linear ablation for atrial fibrillation
41. Long-term follow-up after right atrial radiofrequency catheter treatment of paroxysmal atrial fibrillation
42. Controlled trial of sotalol for one year after myocardial infarction
43. Epidemiologic features of chronic atrial fibrillation: The Framingham study
44. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: Population-based estimates
45. Azimilide dihydrochloride, a novel antiarrhythmic agent
46. Disopyramide in the maintenance of sinus rhythm after electroconversion of atrial fibrillation: A placebo-controlled one-year follow-up study
47. The Ablate and Pace Trial: A prospective study of catheter ablation of the AV conduction system and permanent pacemaker implantation for treatment of atrial fibrillation
48. The natural history of lone atrial fibrillation: A population-based study over three decades
49. Lone atrial fibrillation in elderly persons: A marker for cardiovascular risk
50. How useful is thyroid function testing in patients with recent-onset atrial fibrillation?
51. Comparisons of quality of life and cardiac performance after complete atrioventricular junction ablation and atrioventricular junction modification in patients with medically refractory atrial fibrillation
52. An anatomic approach to prevention of atrial fibrillation: Pulmonary vein isolation with through-the-balloon ultrasound ablation (TTB-USA)
53. Factors predisposing to the development of atrial fibrillation
54. Evaluation of biatrial pacing, right atrial pacing, and no pacing in patients with drug refractory atrial fibrillation
55. Stroke severity in atrial fibrillation. The Framingham Study
56. Cardioversion from atrial fibrillation without prolonged anticoagulation with use of transesophageal echocardiography to exclude the presence of atrial thrombi
57. Electrosurgical treatment of atrial fibrillation with a new intraoperative radiofrequency ablation catheter
58. Prognostic significance of atrial fibrillation in advanced heart failure
59. Transthoracic cardioversion of atrial fibrillation: Comparison of rectilinear biphasic versus damped sine wave monophasic shocks
60. Atrial fibrillation as a self-sustaining arrhythmia independent of a focal discharge
61. A computer model of atrial fibrillation
62. Long-term follow-up after radiofrequency modification of the atrioventricular node in patients with atrial fibrillation
63. Prospective comparison of flecainide versus quinidine for the treatment of paroxysmal atrial fibrillation/flutter
64. AV node ablation and pacemaker implantation after withdrawal of effective rate-control medications for chronic atrial fibrillation: Effect on quality of life and exercise performance
65. Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment
66. Electrocardiographic findings among the adult population of a total natural community, Tecumseh, Michigan
67. Tachycardia-induced cardiomyopathy: A reversible form of left ventricular dysfunction
68. Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia
69. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study
70. Management of patients with atrial fibrillation
71. Pulmonary vein stenosis after catheter ablation of atrial fibrillation
72. Amiodarone to prevent recurrence of atrial fibrillation
73. Clinical spectrum of the sick sinus syndrome
74. New advances in class III antiarrhythmic drug therapy
75. Clinical and prognostic significance of atrial fibrillation in acute myocardial infarction
76. Multisite electrode pacing for prevention of atrial fibrillation
77. Chronic atrial fibrillation and stroke in paced patients with sick sinus syndrome: Relevance of clinical characteristics and pacing modalities
78. The effect of aspirin on the risk of stroke in patients with nonrheumatic atrial fibrillation. The BAATAF study
79. Left upper pulmonary vein stenosis 2 months after radiofrequency catheter ablation of atrial fibrillation
80. Recurrence of paroxysmal atrial fibrillation or flutter after successful cardioversion in patients with normal left ventricular function
81. Pathological effects of extensive radiofrequency energy applications in the pulmonary veins in dogs
82. Dofetilide in patients with congestive heart failure and left ventricular dysfunction
83. Incidence and modes of onset of early reinitiation of atrial fibrillation after successful internal cardioversion, and its prevention by intravenous sotalol
84. Effect of the implantable atrial defibrillator on the natural history of atrial fibrillation
85. Experience with a single-pass, dual-electrode implantable atrial defibrillator lead for maintaining sinus rhythm in patients with recurrent atrial fibrillation
86. Echocardiographic predictors of nonrheumatic atrial fibrillation
87. Effect of left atrial size on recurrence of atrial fibrillation after electrical cardioversion: Atrial dimension versus volume
88. Atrial fibrillation begets atrial fibrillation: A study in awake chronically instrumented goats
89. Electrical remodeling due to atrial fibrillation in chronically instrumented conscious goats: Roles of neurohumoral changes, ischemia, atrial stretch, and high rate of electrical activation
90. Atrial fibrillation: A major contributor to stroke in the elderly. The Framingham Study
91. Impact of atrial fibrillation on mortality, stroke, and medical costs